Based on the discovery that the N-terminal region (amino acids 6-55) of PAQR3 binds to P110α and suppresses the growth of gastric cancer, a synthetic peptide (P6-55) mimicking this region was designed [18]. This evidence concerns the gene PAQR3 and gastric cancer.